The estimated net worth of Ms. Julie Rubinstein is at least $69,557,549 as of 5 Mar 2024. She owns shares worth
$5,852,695 as insider, has earned $59,296,234
from insider trading and has received compensation worth at least
$4,408,620 in Adaptive Biotechnologies Corporation.
What is the salary of Julie Rubinstein?
Ms. Julie Rubinstein salary is $734,770 per year
as Pres in Adaptive Biotechnologies Corporation.
How old is Julie Rubinstein?
Ms. Julie Rubinstein is 53 years old, born in 1972.
What stocks does Julie Rubinstein currently own?
As insider, Ms. Julie Rubinstein owns shares in one company:
What does Adaptive Biotechnologies Corporation do?
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers; and immunoSEQ T-MAP COVID for vaccine developers and researchers to measure the T-cell immune response to vaccines. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. It serves the life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Ms. Julie Rubinstein has made 68 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently she sold
25,580 units of ADPT stock worth $87,739 on 5 Mar 2024.
The largest trade she's
ever made was exercising 80,000 units of ADPT stock
on 24 Dec 2019. As of 5 Mar 2024
she still owns at least 472,754 units of ADPT stock.
Transaction
Date
Security
Shares
Price per share
Total value
Source
Sale
Common Stock
25,580
$3.43
$87,739
Sale
Common Stock
13,490
$3.56
$48,024
Sale
Common Stock
22,668
$8.57
$194,265
Sale
Common Stock
4,613
$12.01
$55,402
Sale
Common Stock
15,000
$58.39
$875,850
Option
Common Stock
15,000
$6.55
$98,250
Option
Stock Option (Right to Buy)
15,000
$6.55
$98,250
Option
Stock Option (Right to Buy)
15,000
$6.55
$98,250
Option
Common Stock
15,000
N/A
N/A
Sale
Common Stock
15,000
$6.55
$98,250
Sale
Common Stock
14,675
N/A
N/A
Option
Stock Option (Right to Buy)
14,675
N/A
N/A
Option
Common Stock
14,675
N/A
N/A
Sale
Common Stock
14,675
$56.73
$832,513
Option
Stock Option (Right to Buy)
15,000
N/A
N/A
Sale
Common Stock
15,000
$57.91
$868,650
Option
Common Stock
15,000
N/A
N/A
Sale
Common Stock
15,000
N/A
N/A
Option
Common Stock
15,000
$6.55
$98,250
Sale
Common Stock
15,000
$55.25
$828,705
Option
Stock Option (Right to Buy)
15,000
$6.55
$98,250
Sale
Common Stock
15,000
$60.68
$910,125
Option
Stock Option (Right to Buy)
15,000
$6.55
$98,250
Option
Common Stock
15,000
$6.55
$98,250
Option
Stock Option (Right to Buy)
15,000
$6.55
$98,250
Option
Common Stock
15,000
$6.55
$98,250
Sale
Common Stock
15,000
$62.27
$934,005
Sale
Common Stock
15,000
$60.85
$912,675
Option
Stock Option (Right to Buy)
15,000
$6.55
$98,250
Option
Common Stock
15,000
$6.55
$98,250
Option
Stock Option (Right to Buy)
15,000
$6.55
$98,250
Sale
Common Stock
15,000
$61.96
$929,325
Option
Common Stock
15,000
$6.55
$98,250
Option
Common Stock
15,000
$6.55
$98,250
Option
Stock Option (Right to Buy)
15,000
$6.55
$98,250
Sale
Common Stock
15,000
$65.05
$975,675
Option
Common Stock
15,000
$6.55
$98,250
Option
Stock Option (Right to Buy)
15,000
$6.55
$98,250
Sale
Common Stock
15,000
$65.87
$987,975
Option
Common Stock
15,000
$6.55
$98,250
Option
Stock Option (Right to Buy)
15,000
$6.55
$98,250
Sale
Common Stock
15,000
$63.4
$950,925
Sale
Common Stock
15,000
$63.5
$952,470
Option
Stock Option (Right to Buy)
15,000
$6.55
$98,250
Option
Common Stock
15,000
$6.55
$98,250
Option
Stock Option (Right to Buy)
15,000
$6.44
$96,525
Sale
Common Stock
15,000
$62.42
$936,225
Option
Common Stock
15,000
$6.44
$96,525
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$62.2
$932,925
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$59.88
$898,200
Option
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$59.01
$885,150
Sale
Common Stock
15,000
$60.12
$901,845
Option
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$59.26
$888,855
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$55.69
$835,275
Sale
Common Stock
15,000
$56.7
$850,545
Option
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$55.87
$838,005
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$59.18
$887,745
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$65.17
$977,505
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$66.71
$1,000,650
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$66.88
$1,003,245
Option
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Sale
Common Stock
8,556
$67.25
$575,391
Sale
Common Stock
15,000
$67.47
$1,012,050
Option
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Sale
Common Stock
14,800
$69.59
$1,029,932
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$70
$1,050,000
Option
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$66.38
$995,655
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$65.92
$988,725
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$63.26
$948,825
Sale
Common Stock
15,000
$62.79
$941,775
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$60.68
$910,200
Sale
Common Stock
15,000
$60.08
$901,170
Option
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Sale
Common Stock
6,186
$60.44
$373,882
Option
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$55.16
$827,325
Option
Common Stock
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$56.27
$844,050
Option
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$57.77
$866,475
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$58.36
$875,400
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$59.84
$897,525
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$60.51
$907,605
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$62.55
$938,280
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$63.89
$958,275
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$64.63
$969,495
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
15,000
$6.32
$94,800
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$63.99
$959,850
Option
Common Stock
15,000
$6.32
$94,800
Sale
Common Stock
15,000
$59.44
$891,525
Option
Stock Option (Right to Buy)
15,000
$6.32
$94,800
Option
Common Stock
14,725
$49
$721,525
Option
Stock Option (Right to Buy)
14,725
$49
$721,525
Sale
Common Stock
14,725
$49
$721,525
Option
Stock Option (Right to Buy)
80,000
$0.84
$67,200
Option
Common Stock
80,000
$0.84
$67,200
Sale
Common Stock
80,000
$0.84
$67,200
Sale
Common Stock
15,275
$0.84
$12,831
Option
Stock Option (Right to Buy)
15,275
$0.84
$12,831
Option
Common Stock
15,275
$0.84
$12,831
Option
Common Stock
30,000
$0.84
$25,200
Option
Stock Option (Right to Buy)
30,000
$0.84
$25,200
Sale
Common Stock
30,000
$38.67
$1,159,950
Sale
Common Stock
80,000
$0.84
$67,200
Option
Common Stock
80,000
$0.84
$67,200
Option
Stock Option (Right to Buy)
80,000
$0.84
$67,200
Option
Common Stock
5,000
$33.55
$167,750
Option
Stock Option (Right to Buy)
5,000
$33.55
$167,750
Sale
Common Stock
5,000
$33.55
$167,750
Sale
Common Stock
80,000
$33.75
$2,700,000
Option
Stock Option (Right to Buy)
80,000
$0.84
$67,200
Option
Common Stock
80,000
$0.84
$67,200
Option
Stock Option (Right to Buy)
80,000
$0.84
$67,200
Option
Common Stock
80,000
$0.84
$67,200
Sale
Common Stock
80,000
$33
$2,640,000
Option
Stock Option (Right to Buy)
40,000
$0.45
$18,000
Option
Common Stock
40,000
$0.45
$18,000
Sale
Common Stock
40,000
$0.45
$18,000
Sale
Common Stock
55,000
$28.82
$1,584,825
Option
Common Stock
55,000
$0.45
$24,750
Option
Stock Option (Right to Buy)
55,000
$0.45
$24,750
Option
Stock Option (Right to Buy)
80,000
$0.45
$36,000
Sale
Common Stock
80,000
$29.28
$2,342,400
Option
Common Stock
80,000
$0.45
$36,000
Sale
Common Stock
80,000
$29.37
$2,349,600
Option
Common Stock
80,000
$0.39
$31,200
Option
Stock Option (Right to Buy)
80,000
$0.39
$31,200
Sale
Common Stock
80,000
$30.35
$2,428,000
Option
Stock Option (Right to Buy)
80,000
$0.33
$26,400
Option
Common Stock
80,000
$0.33
$26,400
Adaptive Biotechnologies key executives
Adaptive Biotechnologies Corporation executives and other stock owners filed with the SEC:
